TGF-β released by apoptotic T cells contributes to an immunosuppressive milieu

Immunity

Volumn 14, Issue 6, 2001, Pages 715-725

  Chen, WanJun ^a   Frank, Mark E ^a   Jin, Wenwen ^a   Wahl, Sharon M ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOSOL; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; INTRACELLULAR MEMBRANE; MACROPHAGE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

EID: 0034960320     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(01)00147-9     Document Type: Article

References (51)

1. Redox-mediated activation of latent transforming growth factor-beta 1
2. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
3. Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation
4. Manipulation of TGF-beta to control autoimmune and chronic inflammatory diseases
5. Peripheral deletion of antigen-reactive T cells in oral tolerance
6. Oral delivery of group A streptococcal cell walls augments circulating TGF-β and suppresses SCW arthritis
7. Engagement of CTLA-4 induces transforming growth factor-β production by murine CD4+ T cells
8. Mechanisms of acquired thymic tolerance in vivo: Intrathymic injection of antigen induces apoptosis of thymocytes and peripheral T cell anergy
9. Smads: Transcriptional activators of TGF-beta responses
10. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF
11. T cells are just dying to accept grafts
12. Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis
13. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes
14. Abrogation of TGF-beta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease
15. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance
16. Location of transforming growth factor-β1 in mitochondria of murine heart and liver
17. Reactive oxygen species regulate activation-induced T cell apoptosis
18. HIV-1 gp160 induces transforming growth factor-beta production in human PBMC
19. Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection
20. TGF-beta: From latent to active
21. Tumor-induced immune dysfunction
22. Interleukin-2 is indispensable for development of immunological self-tolerance
23. The mitochondrion as an integrator/coordinator of cell death pathways
24. Mitochondrial control of apoptosis
25. Interleukin-10-deficient mice develop chronic enterocolitis
26. Transforming growth factor-β null mutation in mice causes excessive inflammatory response and early death
27. Mature T lymphocyte apoptosis - Immune regulation in a dynamic and unpredictable antigenic environment
28. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis
29. Regulation of immune responses by TGF-β
30. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance
31. TGF-β signal transduction
32. Lacrimal gland inflammation is responsible for ocular pathology in TGF-beta 1 null mice
33. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice
34. Apoptosis by death factor
35. The Fas death factor
36. Lethal effect of the anti-Fas antibody in mice
37. Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells
38. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
39. Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection
40. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
41. TGF-beta: 20 Years and counting
42. Reciprocal IFN-γ and TGF-β response regulate the occurrence of mucosal inflammation
43. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance
44. Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes
45. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death
46. Immunosuppressive effects of apoptotic cells
47. Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome
48. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance
49. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
50. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta
51. Inhibition of purified CD34+ hematopoietic progenitor cells by human immunodeficiency virus 1 or gp120 mediated by endogenous transforming growth factor beta 1